English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/60355
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress

AuthorsMecha, Miriam ; Torrao, Andrea S.; Mestre, Leyre ; Carrillo-Salinas, F. J.; Mechoulam, Raphael; Guaza, Carmen
Issue Date28-Jun-2012
PublisherNature Publishing Group
CitationCell Death & Disease 3: e331 (2012)
AbstractCannabidiol (CBD) is the most abundant cannabinoid in Cannabis sativa that has no psychoactive properties. CBD has been approved to treat inflammation, pain and spasticity associated with multiple sclerosis (MS), of which demyelination and oligodendrocyte loss are hallmarks. Thus, we investigated the protective effects of CBD against the damage to oligodendrocyte progenitor cells (OPCs) mediated by the immune system. Doses of 1 μM CBD protect OPCs from oxidative stress by decreasing the production of reactive oxygen species. CBD also protects OPCs from apoptosis induced by LPS/IFNγ through the decrease of caspase 3 induction via mechanisms that do not involve CB1, CB2, TRPV1 or PPARc receptors. Tunicamycin-induced OPC death was attenuated by CBD, suggesting a role of endoplasmic reticulum (ER) stress in the mode of action of CBD. This protection against ER stress-induced apoptosis was associated with reduced phosphorylation of eiF2α, one of the initiators of the ER stress pathway. Indeed, CBD diminished the phosphorylation of PKR and eiF2α induced by LPS/IFNγ. The pro-survival effects of CBD in OPCs were accompanied by decreases in the expression of ER apoptotic effectors (CHOP, Bax and caspase 12), and increased expression of the anti-apoptotic Bcl-2. These findings suggest that attenuation of the ER stress pathway is involved in the 'oligoprotective' effects of CBD during inflammation. © 2012 Macmillan Publishers Limited All rights reserved.
Publisher version (URL)http://doi.org/10.1038/cddis.2012.71
URIhttp://hdl.handle.net/10261/60355
DOI10.1038/cddis.2012.71
Identifiersdoi: 10.1038/cddis.2012.71
issn: 2041-4889
Appears in Collections:(IC) Artículos
Files in This Item:
File Description SizeFormat 
cddis201271.pdf597,98 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.